Literature DB >> 14609920

Novel mutations in the CHST6 gene associated with macular corneal dystrophy in southern India.

John F Warren1, Anthony J Aldave, M Srinivasan, Eugene J Thonar, Abha B Kumar, Vicky Cevallos, John P Whitcher, Todd P Margolis.   

Abstract

OBJECTIVE: To further characterize the role of the carbohydrate sulfotransferase (CHST6) gene in macular corneal dystrophy (MCD) through identification of causative mutations in a cohort of affected patients from southern India.
METHODS: Genomic DNA was extracted from buccal epithelium of 75 patients (51 families) with MCD, 33 unaffected relatives, and 48 healthy volunteers. The coding region of the CHST6 gene was evaluated by means of polymerase chain reaction amplification and direct sequencing. Subtyping of MCD into types I and II was performed by measuring serum levels of antigenic keratan sulfate.
RESULTS: Seventy patients were classified as having type I MCD, and 5 patients as having type II MCD. Analysis of the CHST6 coding region in patients with type I MCD identified 11 homozygous missense mutations (Leu22Arg, His42Tyr, Arg50Cys, Arg50Leu, Ser53Leu, Arg97Pro, Cys102Tyr, Arg127Cys, Arg205Gln, His249Pro, and Glu274Lys), 2 compound heterozygous missense mutations (Arg93His and Ala206Thr), 5 homozygous deletion mutations (delCG707-708, delC890, delA1237, del1748-1770, and delORF), and 2 homozygous replacement mutations (ACCTAC 1273 GGT, and GCG 1304 AT). One patient with type II MCD was heterozygous for the C890 deletion mutation, whereas 4 possessed no CHST6 coding region mutations.
CONCLUSION: A variety of previously unreported mutations in the coding region of the CHST6 gene are associated with type I MCD in a cohort of patients in southern India. CLINICAL RELEVANCE: An improved understanding of the genetic basis of MCD allows for earlier, more accurate diagnosis of affected individuals, and may provide the foundation for the development of novel disease treatments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609920     DOI: 10.1001/archopht.121.11.1608

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  12 in total

1.  Pathogenic mutations of TGFBI and CHST6 genes in Chinese patients with Avellino, lattice, and macular corneal dystrophies.

Authors:  Ya-nan Huo; Yu-feng Yao; Ping Yu
Journal:  J Zhejiang Univ Sci B       Date:  2011-09       Impact factor: 3.066

2.  Macular corneal dystrophy: mutational spectrum in German patients, novel mutations and therapeutic options.

Authors:  Claudia Gruenauer-Kloevekorn; Saskia Braeutigam; Wolfram Heinritz; Ursula G Froster; Gernot I W Duncker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-24       Impact factor: 3.117

Review 3.  The IC3D classification of the corneal dystrophies.

Authors:  Jayne S Weiss; H U Møller; Walter Lisch; Shigeru Kinoshita; Anthony J Aldave; Michael W Belin; Tero Kivelä; Massimo Busin; Francis L Munier; Berthold Seitz; John Sutphin; Cecilie Bredrup; Mark J Mannis; Christopher J Rapuano; Gabriel Van Rij; Eung Kweon Kim; Gordon K Klintworth
Journal:  Cornea       Date:  2008-12       Impact factor: 2.651

4.  Differential immunogold localisation of sulphated and unsulphated keratan sulphate proteoglycans in normal and macular dystrophy cornea using sulphation motif-specific antibodies.

Authors:  Robert D Young; Tomoya O Akama; Petra Liskova; Neil D Ebenezer; Bruce Allan; Briedgeen Kerr; Bruce Caterson; Michiko N Fukuda; Andrew J Quantock
Journal:  Histochem Cell Biol       Date:  2006-08-30       Impact factor: 4.304

5.  A case of Korean patient with macular corneal dystrophy associated with novel mutation in the CHST6 gene.

Authors:  You Kyung Lee; Dong-Jin Chang; Sung Kun Chung
Journal:  Korean J Ophthalmol       Date:  2013-11-15

6.  Genetic analysis of CHST6 and TGFBI in Turkish patients with corneal dystrophies: Five novel variations in CHST6.

Authors:  Fulya Yaylacioglu Tuncay; Gülsüm Kayman Kurekci; Sezen Guntekin Ergun; Ozge Tugce Pasaoglu; Rustu Fikret Akata; Pervin Rukiye Dincer
Journal:  Mol Vis       Date:  2016-10-26       Impact factor: 2.367

7.  Novel mutations of CHST6 in Iranian patients with macular corneal dystrophy.

Authors:  Shiva Akbari Birgani; Zivar Salehi; Masoud Houshmand; Mohamad Javad Mohamadi; Leila Azizade Promehr; Zahra Mozafarzadeh
Journal:  Mol Vis       Date:  2009-02-18       Impact factor: 2.367

8.  Immunophenotypes of macular corneal dystrophy in India and correlation with mutations in CHST6.

Authors:  Afia Sultana; Gordon K Klintworth; Eugene J-M A Thonar; Geeta K Vemuganti; Chitra Kannabiran
Journal:  Mol Vis       Date:  2009-02-09       Impact factor: 2.367

9.  Matrix morphogenesis in cornea is mediated by the modification of keratan sulfate by GlcNAc 6-O-sulfotransferase.

Authors:  Yasutaka Hayashida; Tomoya O Akama; Nicola Beecher; Philip Lewis; Robert D Young; Keith M Meek; Briedgeen Kerr; Clare E Hughes; Bruce Caterson; Akira Tanigami; Jun Nakayama; Michiko N Fukada; Yasuo Tano; Kohji Nishida; Andrew J Quantock
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-25       Impact factor: 11.205

10.  Molecular analysis of the CHST6 gene in Korean patients with macular corneal dystrophy: Identification of three novel mutations.

Authors:  Shin Hae Park; Ye Jin Ahn; Hyojin Chae; Yonggoo Kim; Man Soo Kim; Myungshin Kim
Journal:  Mol Vis       Date:  2015-10-26       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.